BIO PHARMA

Serial Number 97815309
731

Registration Progress

Application Filed
Feb 28, 2023
Under Examination
Jun 4, 2024
Approved for Publication
Apr 9, 2024
Published for Opposition
Apr 9, 2024
Registered

Trademark Image

BIO PHARMA

Basic Information

Serial Number
97815309
Filing Date
February 28, 2023
Published for Opposition
April 9, 2024
Drawing Code
3

Status Summary

Current Status
Active
Status Code
731
Status Date
Jun 5, 2025
Application
Pending
Classes
005 040 042

Rights Holder

OFD BioPharma, LLC

16
Address
525 25th Ave SW
Albany, OR 97322

Ownership History

OFD BioPharma, LLC

Original Applicant
16
Albany, OR

OFD BioPharma, LLC

Owner at Publication
16
Albany, OR

Legal Representation

Attorney
Ernest G. Bootsma

USPTO Deadlines

All Deadlines Cleared

All 3 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

26 events
Date Code Type Description Documents
Sep 15, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 5, 2025 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jun 4, 2025 EXT2 S SOU EXTENSION 2 FILED Loading...
Jun 4, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 3, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 1, 2024 EX1G S SOU EXTENSION 1 GRANTED Loading...
Dec 1, 2024 EXT1 S SOU EXTENSION 1 FILED Loading...
Dec 1, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 4, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Apr 9, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Apr 9, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 20, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Mar 1, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Feb 29, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Feb 29, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Feb 29, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Nov 30, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Nov 30, 2023 GNRT O NON-FINAL ACTION E-MAILED Loading...
Nov 30, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Nov 30, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Nov 30, 2023 GNRT F NON-FINAL ACTION E-MAILED Loading...
Nov 30, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Nov 28, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 21, 2023 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Mar 19, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Mar 3, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Drug delivery agents in the form of capsules, powders, tablets, intra-nasal spray, intra-nasal mist, dissolvable films, and pastilles that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of transdermal patches that facilitate the delivery of pharmaceutical preparations
Class 040
Custom manufacture of pharmaceuticals; material transformation services, namely, freeze drying compounds in the nature of active pharmaceutical ingredients and biologicals for pharmaceuticals and nonfood articles; Material transformation services, namely, freeze drying food products and nonfood articles
Class 042
Research and development of technology in the fields of freeze drying and packaging; technical research in the field of pharmaceutical studies; consulting services in the field of biotechnology; pharmaceutical research and development; pharmaceutical products development; Research and development services in the fields of foods, freeze drying and packaging

Additional Information

Design Mark
The mark consists of an open circle with an opening on the top right portion of the circle, with a horizontal line extending into the opening of the circle followed by the words "BIO | PHARMA".
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
005 040 042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"BIO PHARMA"